Finasteride may improve prostate cancer therapy by enhancing testosterone's benefits and reducing risks.
9 citations
,
September 2009 in “The Prostate” Finasteride doesn't improve survival in LNCaP tumor model during off-cycle of therapy.
1 citations
,
January 2010 in “Endocrine abstracts”